ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 121

The Diagnostic Value of Color Doppler Ultrasonography in Giant Cell Arteritis

Merete L. Hetland1, Geirmund Myklebust2, Glenn Haugeberg3 and Andreas P. Diamantopoulos4, 1Copenhagen University Hospital Glostrup, Copenhagen, Denmark, 2Rheumatology, Hospital of Southern Norway HF, Kristiansand, Norway, 3Rheumatology, Hospital of Southern Norway Trust, Kristiansand, Norway, 4Department of Rheumatology, Hospital of Southern Norway Trust, Kristiansand, Norway

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Clinical research methods, ultrasound and vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Imaging of Rheumatic Diseases: Ultrasound, Nuclear Medicine and Fluorescence Imaging

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Color Doppler Ultrasonography (CDUS) has been shown to be a non-invasive promising tool to diagnose Giant Cell Arteritis (GCA). The aim of our study was to evaluate the diagnostic value of CDUS in patients suspected to have GCA in clinical care.

Methods:

Patients referred to our outpatient clinic between January 2010 and April 2012 with a tentative diagnosis of GCA were consecutively examined. A clinical evaluation was performed and the temporal arteries and the large vessels (carotid and axillary arteries) were assessed using a Siemens Acuson Antares ultrasound system (high frequency transducer 7-14 MHz). CDUS was considered positive when the typical sign of halo (arterial wall swelling in transverse and longitudinal view) was observed in the temporal arteries. The patients were diagnosed with large vessels vasculitis (LVV) when intima-media complex thickness was homogenous and more than 1.5 mm in the carotid artery and more than 1 mm in the axillary artery. After the CDUS examination, unilateral biopsies of the temporal artery were carried out in the majority of the patients. The diagnostic value of CDUS, temporal artery biopsy and the American College of Rheumatology classification criteria for the GCA (ACR-GCA) were tested against the gold standard, for this study defined as final clinical GCA diagnosis established by an experienced rheumatologist.

Results:

Seventy-eight patients (48 females, 30 males) were successively referred to our outpatient clinic. Thirty-six were diagnosed with GCA (27 females, 9 males) and all of them had a positive CDUS of the temporal artery. In addition, we found 4 patients with positive CDUS of the temporal artery but with other diagnoses (1 polyarteritis nodosa, 1 granulomatosis with polyangiitis and 2 with infections). Among the 36 patients with GCA, 32 fulfilled the ACR-GCA classification criteria. Temporal artery biopsy was positive in 20 of the 28 GCA patients who had a biopsy performed. Large vessel involvement was observed in 13 patients (36%). The mean time between the first presentation of symptoms and the diagnosis was 2.3 months (3.0 months in GCA patients with LVV and 1.7 months in classic GCA). In our series, sensitivity and specificity was 100% and 91% for CDUS, 64% and 95% for the temporal artery biopsy and 94% and 90% for the ACR-GCA classification criteria, respectively.

Conclusion:

We conclude that CDUS has an excellent sensitivity and a high specificity to diagnose GCA in daily clinical care. CDUS do also have the advantage to identify large vessel involvement in GCA patients. We recommend the use of CDUS as a first line assessment tool in diagnosing GCA.


Disclosure:

M. L. Hetland,
None;

G. Myklebust,
None;

G. Haugeberg,

DiaGraphIT,

1;

A. P. Diamantopoulos,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-diagnostic-value-of-color-doppler-ultrasonography-in-giant-cell-arteritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology